Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

about

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

Item

http://www.wikidata.org/entity/Q38639401

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

@en

type

Item

label

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

@en

altLabel

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I

@en

prefLabel

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

@en

P1476

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

@en

P2093

Eva Sullivan

http://www.w3.org/2001/XMLSchema#string

Nancy F Crum-Cianflone

http://www.w3.org/2001/XMLSchema#string

P2860

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology

Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Risk of Invasive Meningococcal Disease in Men Who Have Sex with Men: Lessons Learned from an Outbreak in Germany, 2012-2013

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature

Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.

High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults.

Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.

P2888

s40121-017-0166-x

P304

303-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-017-0166-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090995131

http://www.w3.org/2001/XMLSchema#string

P698

28779442

http://www.w3.org/2001/XMLSchema#string

P932

5595780

http://www.w3.org/2001/XMLSchema#string